CCR2 and glomerulonephritis: Treatment with anti-CCL2 antibodies and CCR2 inhibitors suppresses urine protein leakage and inflammation in the tubulointerstitium and glomeruli and decreases the migration of macrophages into these tissues in a rat model of glomerulonephritis (Wada and Yokoyama 1996).